206 related articles for article (PubMed ID: 36155281)
1. Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway.
Xie KH; Liu XH; Jia J; Zhong X; Han RY; Tan RZ; Wang L
Int Immunopharmacol; 2022 Nov; 112():109247. PubMed ID: 36155281
[TBL] [Abstract][Full Text] [Related]
2. Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation.
Hui D; Rui-Zhi T; Jian-Chun L; Xia Z; Dan W; Jun-Ming F; Li W
J Ethnopharmacol; 2020 Apr; 252():112637. PubMed ID: 32004631
[TBL] [Abstract][Full Text] [Related]
3. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM
Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190
[TBL] [Abstract][Full Text] [Related]
4. Abnormal lncRNA CCAT1/microRNA-155/SIRT1 axis promoted inflammatory response and apoptosis of tubular epithelial cells in LPS caused acute kidney injury.
Lu S; Dong L; Jing X; Gen-Yang C; Zhan-Zheng Z
Mitochondrion; 2020 Jul; 53():76-90. PubMed ID: 32243922
[TBL] [Abstract][Full Text] [Related]
5. The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/β-Catenin Signaling.
Dong X; Cao R; Li Q; Yin L
Nephron; 2022; 146(2):209-219. PubMed ID: 34818249
[TBL] [Abstract][Full Text] [Related]
6. Isorhamnetin ameliorates cisplatin-induced acute kidney injury in mice by activating SLPI-mediated anti-inflammatory effect in macrophage.
Jian J; Yu-Qing L; Rang-Yue H; Xia Z; Ke-Huan X; Ying Y; Li W; Rui-Zhi T
Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):319-329. PubMed ID: 38466121
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.
Iwakura T; Zhao Z; Marschner JA; Devarapu SK; Yasuda H; Anders HJ
Nephrol Dial Transplant; 2019 Oct; 34(10):1669-1680. PubMed ID: 30624740
[TBL] [Abstract][Full Text] [Related]
8. Effect of lncRNA CRNDE on sepsis-related kidney injury through the TLR3/NF-κB pathway.
Sun BQ; Sui YD; Huang H; Zou XB; Chen SC; Yu ZK
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10489-10497. PubMed ID: 31841203
[TBL] [Abstract][Full Text] [Related]
9. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
Jiao X; Cai J; Yu X; Ding X
Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
[TBL] [Abstract][Full Text] [Related]
10. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
11. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death.
Gao L; Liu MM; Zang HM; Ma QY; Yang Q; Jiang L; Ren GL; Li HD; Wu WF; Wang JN; Wei B; Liu XQ; Jiang C; Huang C; Li J; Meng XM
Lab Invest; 2018 Jul; 98(7):911-923. PubMed ID: 29581579
[TBL] [Abstract][Full Text] [Related]
12. Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α.
Zhou X; Jiang K; Luo H; Wu C; Yu W; Cheng F
Int Immunopharmacol; 2020 Jun; 83():106472. PubMed ID: 32278129
[TBL] [Abstract][Full Text] [Related]
13. Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death.
Shan RR; Yu JT; Zhang SF; Xie MM; Hou R; Xie CY; Dong ZH; Yang Q; Hu XW; Dong YH; Zhang Y; Luo XF; Cui ZY; Liu XY; Xie YC; Wen JG; Liu MM; Jin J; Chen Q; Meng XM
Phytomedicine; 2024 Jan; 123():155252. PubMed ID: 38056145
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects of Apamin in a Murine Model of Lipopolysaccharide-Induced Acute Kidney Injury.
Kim JY; Leem J; Park KK
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287398
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis.
Yang J; Wu L; Liu S; Hu X; Wang Q; Fang L
Med Microbiol Immunol; 2021 Jun; 210(2-3):121-132. PubMed ID: 33885954
[TBL] [Abstract][Full Text] [Related]
16. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
Zhou P; Wu M; Ye C; Xu Q; Wang L
J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
[TBL] [Abstract][Full Text] [Related]
17. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2.
Yang Y; Liu S; Gao H; Wang P; Zhang Y; Zhang A; Jia Z; Huang S
Free Radic Biol Med; 2020 May; 152():821-837. PubMed ID: 32004633
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome sequencing of circular RNA reveals a novel circular RNA-has_circ_0114427 in the regulation of inflammation in acute kidney injury.
Cao Y; Mi X; Zhang D; Wang Z; Zuo Y; Tang W
Clin Sci (Lond); 2020 Jan; 134(2):139-154. PubMed ID: 31930399
[TBL] [Abstract][Full Text] [Related]
20. Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.
Yang Q; Ren GL; Wei B; Jin J; Huang XR; Shao W; Li J; Meng XM; Lan HY
Theranostics; 2019; 9(26):8277-8293. PubMed ID: 31754396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
